VALUE OF THE COMBINED TEST
IN PRENATAL DIAGNOSTICS
Lončar D
*Corresponding Author: Dragan Lončar, Gynecology and Obstetrics Clinic, Clinical Center
Kragujevac , Vojislava Kalanovića 1A/3, 34000 Kragujevac, Serbia; Tel.: +381-64-616-8999;
E-mail: drloncar@sezampro.rs
page: 53
|
|
REFERENCES
1. Ebrahim S, Daponte A, Guidozzi F. The
impact of free antenatal care on perinatal mortality.
Int J Gynaecol Obstet. 2000; 71(3): 205-207.
2. Alfirevic Z, Neilson JP. Antenatal screening
for Down’s syndrome. Br Med J. 2004; 329(7470):
811-812.
3. Spencer K. Age related detection and false
positive rates when screening for Down’s syndrome
in the first trimester using fetal nuchal translucency
and maternal serum βhCG and PAPP-A. Br J Obstet
Gynaecol. 2001; 108: 1043-1046.
4. Wald NJ, Watt HC, Hackshaw AK. Integrated
screening for Down’s syndrome on the basis of tests
performed during the first and second trimesters. N
Engl J Med. 1999; 341(7): 461-467.
5. Wald NJ, Rodeck C, Hackshaw AK, Walters
J, Chitty L, Mackinson AM. First and second
trimester antenatal screening for Down’s syndrome:
the results of the Serum, Urine and Ultrasound
Screening Study (SURUSS). J Med Screen. 2003;
10(2): 56-104. (Erratum in: J Med Screen. 2006;
13(1): 51-52.)
6. Stojilkovic-Mikic T, Rodeck CH. Screening
for chromosomal anomalies: first or second
trimester, biochemical or ultrasound? Ann Acad
Med Singapore. 2003; 32(4): 583-589.
7. Haddow JE, Palomaki GE, Knight GJ,
Williams J, Miller WA, Johnson A. Screening of
maternal serum for fetal Down’s syndrome in the
first trimester. N Engl J Med. 1998; 338(14): 955-
961.
8. Wald NJ, George L, Smith D, Densem JW,
Petterson K. Serum screening for Down’s syndrome
between 8 and 14 weeks of pregnancy. International
Prenatal Screening Research Group. Br J Obstet
Gynaecol. 1996; 103(5): 407-412.
9. Snijders RJM, Farrias M, Kaisenberg C,
Nicolaides KH. Fetal abnormalities. In: Sniijders
RJM, Nicolaides KH, Eds. Ultrasound Markers for
Fetal Chromosomal Defects. New York: Parthenon,
1996: 1-63.
10. Cunningham FG, Leveno KJ, Bloom SL,
Hauth JC, Gilstrap L, Wenstrom KD, Eds. Prenatal
diagnosis and fetal therapy. Williams Obstetrics.
New York: McGraw-Hill, 2005: 313-340.
11. Wellesley D, Boyle T, Barber J, Howe DT.
Retrospective audit of different antenatal screening policies for Down’s syndrome in eight district
general hospitals in one health region. Br Med J.
2002; 325(7354): 15-17.
12. Lončar D, Varjačić M, Novaković
T, Milovanović D, Janković S. Correlation
between serum biochemical markers and early
amniocentesis in diagnosis of congenital fetal
anomalies. Bosnian J Basic Med Sci. 2010; 10(1):
9-14.
13. Hallahan T, Krantz D, Orlandi F, Rossi C,
Curcio P, Macri S, Larsen J, Buchanan P, Macri
J. First trimester biochemical screening for Down
syndrome: free β-hCG versus intact hCG. Prenat
Diagn. 2000; 20(10): 785-789.
14. Brigatti KW, Malone FD. First trimester
screening for aneuploidy. Obstet Gynecol Clin
North Am. 2004; 31(1): 1-20.
15. Nicolaides KH. Nuchal translucency
and other first-trimester sonographic markers
of chromosomal abnormalities. Am J Obstet
Gynecol. 2004; 191(1): 45-67.
16. Spencer K, Souter V, Tul N, Snijders R,
Nicolaides KH. A screening program for trisomy 21 at
10-14 weeks using fetal nuchal translucency, maternal
serum free β-human chorionic gonadotropin and
pregnancy-associated plasma protein-A. Ultrasound
Obstet Gynecol. 1999; 13(4): 231-237.
17. Krantz DA, Hallahan TW, Orlandi F,
Buchanan P, Larsen JW Jr, Macri JN. Firsttrimester
Down syndrome screening using dried
blood biochemistry and nuchal translucency. Obstet
Gynecol. 2000; 96(2): 207-213.
18. Spencer K, Spencer CE, Power M, Moakes
A, Nicolaides KH. One stop clinic for assessment of
risk for fetal anomalies: a report of the first year of
prospective screening for chromosomal anomalies
in the first trimester. Br J Obstet Gynaecol. 2000;
107(10): 1271-1275.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
